WO2007107796A1 - Improvements in treatment of dry powder formulations - Google Patents
Improvements in treatment of dry powder formulations Download PDFInfo
- Publication number
- WO2007107796A1 WO2007107796A1 PCT/GB2007/050142 GB2007050142W WO2007107796A1 WO 2007107796 A1 WO2007107796 A1 WO 2007107796A1 GB 2007050142 W GB2007050142 W GB 2007050142W WO 2007107796 A1 WO2007107796 A1 WO 2007107796A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- powder
- receptacle
- vibrational
- blister
- khz
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
- A61M15/001—Details of inhalators; Constructional features thereof with means for agitating the medicament using ultrasonic means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/30—Mixers with shaking, oscillating, or vibrating mechanisms comprising a receptacle to only a part of which the shaking, oscillating, or vibrating movement is imparted
- B01F31/31—Mixers with shaking, oscillating, or vibrating mechanisms comprising a receptacle to only a part of which the shaking, oscillating, or vibrating movement is imparted using receptacles with deformable parts, e.g. membranes, to which a motion is imparted
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
- B01F31/86—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations with vibration of the receptacle or part of it
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/60—Mixing solids with solids
Definitions
- the present invention relates to the treatment of dry powder formulations, doses of which are measured out and placed into receptacles such as blisters or capsules, to be dispensed by a dry powder inhaler device (DPI).
- DPI dry powder inhaler device
- the present invention relates to methods of agitating a dose of a dry powder formulation to ensure that any compacted powder is broken up It is easier to extract a loose powder from a receptacle than it is to extract powder which is compacted and so ensuring that the powder in a receptacle is not compacted can, in turn, lead to improvements in the administration of the powder formulation to the lung of the patient
- DPIs commonly utilise receptacles, such as capsules or foil blisters, within which individual doses of the dry powder medicament are stored in a dry and protected environment.
- receptacles such as capsules or foil blisters
- the compacts may be too large to enter the exit conduit of the inhaler device, the compacts may become trapped under the foil flaps of conventional blisters, the compacts may become wedged into blister or capsule crevices, and/or combinations of these problems.
- the blister or capsule emptying may be improved by incorporating device modifications that are designed to allow the inhaler device to tolerate larger lumps of powder, for example by including a larger exit port.
- the compacts can still have a detrimental effect on the pulmonary delivery of the powder formulation, which is very much dependent on particle size.
- compacted masses or plugs tend to be formed when the powders include a high proportion of fine particles which have a particle size of about 20 ⁇ m or less, and particularly of about lO ⁇ m or less.
- the issue with such fine powders is believed to be their tendency to agglomerate and to form one or more large compacted lumps of powder during machine-filling.
- Machine filling of dry powder formulations does not tend to present such a problem when the dry powder formulations include larger particles, such as large carrier particles with a particle size of 35 ⁇ m or greater. These larger particles have a significant influence on the powder properties and in particular on the tendency of the powder particles to agglomerate and the flowability of the powder, with the larger particles acting a fluidismg means.
- Sieving can improve blister or capsule emptying.
- a dry powder formulation including a high proportion of fine particles exhibits the above discussed compaction problems when doses are measured out and transferred to blisters or capsules mechanically
- the inhaler exhibits drastically improved blibter or capsule emptying.
- sieving does not represent a practical solution to the problems associated with the compacted powder observed when blisters and capsules are machine filled.
- Sieving can only be practically conducted prior to loading powder into the filling machine Sieving cannot be conducted after filling as powder may be lost upon contact with the sieve and filling accuracy may therefore be compromised. Indeed, any direct physical contact with the powder to provide mechanical dispersion of compacts appears to be potentially undesirable.
- the method needs to be effective, not only in breaking up compacted powder, but preferably also m ensuring that the powder does not become coated or caked on the inner surface of the receptacle within which it is stored. Preferably, the powder also does not become segregated.
- a method for agitating a measured dose of a dry powder formulation, so that any compacted powder is broken up and is present in a respirable form.
- respirable form it is meant that the powder is in a deaggregated form and that, upon being dispensed by a DPI, the powder will be dispensed so that the active agent present in the powder is in the form of particles or particle agglomerates of respirable size (preferably having a diameter of 10 ⁇ m or less).
- the powder in respirable form may include small agglomerates of particles, as are present in an ordered mixture, for example where the powder comprises fine particles of a pharmaceutically active agent and larger particles of a carrier material, to which the fine particles adhere. Any agglomerates present in the powder in respirable form may be broken up by the turbulence created upon actuation of the DPI.
- the respirable nature of the resultant powder may be ascertained by ACI (Anderson Cascade Impactor) data, such as that shown in Example 7
- ACI Anderson Cascade Impactor
- the data shows that the powder plug is not in respirable form prior to agitation in accordance with the invention, but it is considered to be respirable after such treatment.
- the respirable powder has a Fine Particle Fraction of greater than 50.
- the step of breaking up compacted powder involves agitating the powder with force sufficient to break up the compacted powder.
- Receptacles are containers, such as blisters and capsules, into which measured or metered doses of dry powder formulations are placed for storage and from which the dose of powder may be dispensed by a DPI.
- a method for agitating a measured dose of a dry powder formulation which is in a sealed receptacle comprising indirectly applying a vibrational force to the powder, for example via the air within the sealed receptacle.
- this is achieved by applying the vibrational force to a flexible wall of the receptacle.
- the agitation involves applying a vibrational force using a vibrational means, wherein the vibrational force is not applied directly to the receptacle at the point where the powder contacts the receptacle.
- the powder is preferably agitated following the powder-measuring step, which is usually carried out by a blister or capsule-filling machine.
- the vibrational force may be provided in the form of sonication, including acoustic and ultrasound agitation (including resonant frequency matching), shaking, impacts and percussion effects.
- the vibration may be applied to the outside of the sealed receptacle, and is communicated to the powder compact held inside the receptacle, preferably through the air in the receptacle (in preference to the vibration being communicated through the body of the receptacle, at least part of which will be in direct contact with the powder compact.
- Known means may be used to focus or transfer the vibrational forces, such as an acoustic lens, or transmitting media to improve contact with the sealed receptacle.
- the means used to apply the vibrational force may be an acoustic lens.
- the means of applying the vibrational force is a sonotrode.
- Preferred agitation methods include applying a vibrational force to the powder in the receptacles at frequencies of less than about 1 megahertz.
- the frequency is from about 1 Hz to about 500 kHz, from about 1 kHz to about 250 kHz, from about 10 kHz to about 100 kHz, from about 15 kHz to about 50 kHz, or from about 20 kHz to about 40 kHz.
- the agitation may be provided by contacting the filled receptacle with an ultrasonic probe, for example a probe which is operating at a frequency range of between about 10 and about 40 kHz.
- the amplitude of oscillation of the vibrational force is also a key factor. It has been found that application of a vibrational force with a particular amplitude to a receptacle improves the break up of powder compacts and can assist in subsequent emptying of the receptacle.
- the amplitude of the vibrational force should be between about 10 to about 100%, more preferably from about 50 to about 100%. Especially preferred amplitudes range from about 75 to about 100%, from about 80 to about 100%, from about 85 to about 100% or from about 90 to about 100%.
- the skilled person would have no difficulty in ascertaining the suitable amplitude in order to break up powder compact, based upon the nature of the powder, the nature of the compacts formed during receptacle filling and the nature of the receptacle.
- the pressure with which the vibrational force is applied to the receptacle has been found to be an important factor in achieving effective break up of powder compacts and improving the emptying of the receptacle upon actuation of the DPI.
- Preferred pressures include ranges from about 0.1 to about 1.5 bar, from about 0.2 to about 1.2 bar and most preferably from about 0.2 to about 0.6 bar.
- the value of the pressure parameter lies in its application to a sealed environment.
- the vibrational force should be applied for between about 0.01 and 10 seconds.
- the vibrational force needs to be applied for long enough to allow complete break up or deaggregation of the compacted powder, but must not be so long as to have any detrimental effects on the powder, for example by causing ordered mixtures to segregate.
- the vibrational force is applied for between about 0.025 to about 1 second.
- the duration may need to be adjusted, depending upon the other parameters. For example, a lower frequency vibrational force may need to be applied for longer in order to have the desired effect.
- the skilled person would have no difficulty in establishing the optimum duration, without requiring inventive input or overly onerous experimentation.
- positioning the vibrational surface of the vibrational means against the receptacle creates a cavity, an empty space between the surfaces.
- This cavity is preferably sealed, and most preferably, an airtight seal is formed.
- the vibrational force causes the air within the cavity to vibrate and this vibration is transmitted to the air within the receptacle.
- the vibrational force is provided by a probe which has a recessed surface, for example a concave vibrational surface.
- the vibrational force is generated by the probe causes the air to vibrate within the cavity of the probe formed by this recessed surface.
- a sealed air entity Upon contact of the probe with the sealed surface of the receptacle (for example, a blister), a sealed air entity is created.
- the air withm the temporarily sealed unit is able to expand and contract with each oscillation of the sonotrode.
- These expansions and contractions of the air within the probe cavity are then transferred through the lid of the blister into the blister contents namely air and powder.
- Provided enough flexibility is afforded to the blister a synchronous expansion- contraction of the air occurs within the sealed blister unit.
- Figure 1 is a photograph of standard powder plugs in unsealed receptacles
- Figure 2 is a schematic representation of a standard blister for use in a DPI
- Figure 3 is a schematic, partial representation of a vibrational means, including the vibrational surface
- Figure 4 is a schematic representation of a shaped or bespoke vibrational surface of a vibrational means
- Figure 5 to 8 are schematic representations of the various different arrangements by which a sonotrode may be applied to a blister in order to agitate powder held within the blister;
- Figure 9 is a schematic diagram of the different shape sonotrode that is useful in the present invention.
- Figure 10 is a photograph of a blister containing a dose of powder after treatment using a method according to the present invention.
- FIG. 11 to 16 are graphs showing the results of the experiments described in
- a conventional blister for use m a DPI is schematically shown in Figure 2
- the blister 1 comprises a cup-shaped body 2, within which a dose of powder may be held
- the open end of this cup-shaped body is sealed by a foil covering 3 or lid, that is sealed to the body around a shoulder area 4.
- a vibrational means 10 such as a sonotrode as shown in Figure 3
- the surface 11 of the vibrational means which contacts the blister is flat, as shown in Figure 3a
- FIG 5 shows how the shaped vibrational surface shown in Figure 4a might conventionally have been used
- the vibrational means is positioned in order to agitate the receptacle and its contents.
- the vibrational surface is placed in direct contact with the base of the blister
- the powder will lie in contact with the base of the blister and will therefore be in contact with the part of the blister wall which is in contact with the vibrational means
- the vibrational force is passed through the wall of the blister body and directly to the powder
- the arrangement as outlined in Figure 7 is less tolerant of "extreme" parameters. Should frequency or energy duration be exceeded the foil seals are prone to rupturing and the plastic blister walls are susceptible to melting.
- the sonication arrangement outlined in Figure 7 would appear to be the sensible; however the sonication assembly is suboptimal as misdirected energy in the form of heat compromises blister seal integrity
- the energy from the flat surface of the sonotrode encounters the flat surface of the blister imparting high localised vibration energy on the foil and seal which conventional blister materials are not designed to withstand
- the advantage of the arrangement as outlined in Figure 8 is the energy is not focused on the blister foil but exploits the blister foil to convey the pressure waves via the air contained in the hermetically sealed blister into the air of the powder plug It has also been found that application of the flat surface of the vibrational means to the upper, flat surface of the blister, as demonstrated by Figure 7, does not provide optimal emptying of the blister.
- the greatest improvement in the break up of the powder compacts and subsequent improved blister emptying is achieved by the arrangement shown in Figure 8.
- the recessed, cup-shaped surface 12 of the vibrational means 10 is positioned so that it contacts the foil lid 3 of the blister 1, rather than the cup- shaped body 2 of the blister.
- the cup-shaped portion of the vibrational means is substantially aligned with the cup-shaped portion of the blister or capsule, as illustrated in Figure 8.
- the cup-shaped portion of the receptacle is merely supported with no vibration.
- the vibrational surface when the vibrational surface contacts the receptacle, there is a gap between at least part of the vibrational surface and the surface of the receptacle
- This gap may be described as a cavity and the cavity is preferably sealed, i.e. it is surrounded by no gap between the vibrational surface and the receptacle
- this arrangement is achieved by the vibrational surface of the vibrational means being concave in shape.
- the depth of the concave vibration surface or cup- shaped indentation in the vibrational means can affect deaggregation of the powder compact and subsequent emptying of the blister or capsule (see Figure 9).
- the ratio between the cup-shaped indentation of the surface of the vibrational means and the depth of the cup of the blister is significant as this provides greater facility for oscillating the air within the blister.
- the depth of the indentation in the vibrational means is between 0.01 and 99% greater than the depth of the blister or capsule (B in Figure 9), between 0.1 and 90% greater, between 1 and 80% greater, between 5 and 50% greater, or between 10 and 20% greater than the depth of the blister or capsule
- the improvement in the break up of the powder compact, and the subsequent improvement in receptacle emptying, resulting from the use of a vibrational means which creates a cavity upon application to the receptacle, may be improved by an arrangement in which the cavity has a particular volume, preferably the volume is equivalent to at least 0.1% the volume of the blister. This may again result from the reduction in caking of the powder resulting from the distal location of the vibrating surface from the powder.
- the compression and rarefaction of air in the pocket between the vibrating surface of the vibrational means, and the blister or capsule surface, the volume of which is determined by the depth of the indentation may also contribute to the improved emptying
- the cup-shaped portion of the receptacle is located in a similarly shaped (i.e. a cup shaped) holder.
- the vibrational means may then be applied to the opposite surface of the receptacle. It is believed that this arrangement ( Figure 5) results in dissipation of the energy of vibration throughout the receptacle, as a result of the contact surface area between the receptacle and the receptacle.
- the cup-shaped portion of the receptacle should be supported by a similarly shaped holder as this provide support for the blister. Full contact between the holder and receptacle will dissipate energy if the holder is not the sonotrode.
- Improvements in the break up of the powder compacts and in subsequent emptying of the receptacle may be achieved by optimisation of the means used to hold the receptacle.
- improved results may be achieved by proving a holder that directs or concentrates the energy of vibration onto one or more points of the receptacle.
- the cup-shaped portion of the blister or capsule could be held in a holder comprising three-prongs. This obviously reduces the contact area between the holder and the receptacle.
- each of the parameters discussed above namely the arrangement of the receptacle, vibrating means and holder, or the properties of the vibrational force generated by the vibrational means, have an influence.
- These parameters should be selected to provide a complete break up of the powder compacts, to provide a finely divided loose powder, but should not have a detrimental effect on the powder formulation, for example by causing undesirable segregation of the powder.
- the ideal combination of parameters may be established by the skilled person without inventive input and without the need for excessive trial and error, especially based upon the preferred embodiments set out below.
- the nature of the powder, the nature of the compacts formed during receptacle filling and the nature of the receptacle itself may affect the values selected for each parameter, as the skilled person would recognize.
- some powder formulations may contain additive materials in order to reduce the cohesion and/or adhesion of ad j acent particles
- the inclusion of additive materials may mean that the selected parameters may need to be different to those used in connection with a powder which does not contain additive materials.
- particular arrangements of the receptacle, vibrating means and holder, and/or particular values within the preferred ranges are selected for two or more of the parameters specified above, in order to improve subsequent blister emptying.
- particular arrangements of the receptacle, vibrating means and holder, and particular values within the preferred ranges are selected for all of the parameters specified above.
- the pressure with which the vibrational force is applied to the blister or capsule is between about 0.2 to about 0.6 bar; the frequency of vibration is between about 20 to about 35 kHz; the amplitude of vibration is between about 50 to about 100%; and/or the duration of application of the vibrational means is between about 0.01 and about 1 second.
- the shape of the powder plug also appears to have an effect on the deaggregation methods. From the experimental data set out in the Examples below, it would appear that an elongated or "sausage-shaped" pellet is dispersed more effectively compared to "normal" plugs, examples of which are shown in Figure 1.
- the method involves agitation of elongated powder pellets, plugs or compacts. These elongated compacts have a greater surface area to volume ratio than the standard compacts. They also preferably have an aspect ratio of greater than 1 :1, preferably greater than 4: 3 or greater than 2:1. Where the compacts are cylindrical in shape, the ratio of the length to diameter is greater than I -I , preferably greater than 4: 3, greater than 2:1 or greater than 3:1.
- Another aspect to the powder is the air content of the compacted metered powder
- a dense, low air content powder will not have the same ability to compress and rarefact compared to powders with slightly higher air content.
- Highly compacted powders have particles in close proximity, greater surface contact between neighbouring particles, minimal air gaps and high interparticulate adhesion and cohesion forces.
- powders with particles exhibiting less surface contact between neighbouring particles will consequently have greater air spaces which can be exploited for the compression rarefaction cycles
- dense plugs will require greater sonication exposure to generate the greater air gaps to generate the deaggregated powders suitable for predictable drug delivery.
- the step of agitating the powder comes immediately after the receptacle is machine-filled
- the vibrational means is provided as part of the machine used to fill the receptacles
- the vibrational means is provided in the DPI, so that the powder is agitated immediately prior to dispensing the powder for pulmonary delivery to a patient The agitation may take place upon priming or actuating the DPI
- receptacles such as blisters and capsules are provided which have been filled and treated using the methods according to the first and second aspects of the invention.
- dry powder inhaler devices comprise receptacles such as blisters or capsules according to the third aspect of the invention.
- the invention described herein is applicable to powder-filled receptacles such as blisters and capsules for use in both active dry powder inhaler devices, such as Aspirair® (Vectura Limited) and Exubera® (Nektar Therapeutics), as well as in passive devices such as the Diskus® (Glaxo) and GyroHaler® (Vectura Limited)
- a receptacle-filling apparatus which measures doses of dry powders and places these into receptacles, and subsequently agitates the powder-filled receptacles, in accordance with the first and second aspects of the invention
- the agitation methods could form part of the production line preparing filled receptacles.
- Example 1 Sonication of blisters filled by table-top fillet Two dry powder formulations comprising micronised clomipramine and magnesium stearate were prepared by co-micronising the two components together. These powders comprised 2% or 5% magnesium stearate
- the powders were then filled into foil blisters using a Harro-Hoffliger (HH) table- top mechanical filler, which meters the powders into plug-shaped forms.
- HH Harro-Hoffliger
- Plugs were typically 3mg fill weight. Two types of plug shape from the filler were evaluated: a regular plug shape and a longer aspect "sausage" shape. Also the air vacuum applied to form the plug was varied from 5 psi to 10 psi, with the higher value expected to form more compacted plugs.
- the sonicated blisters were fired from an Aspirair device and the percentage of the mass emptied was measured The results, which are set out in Table 1 below, consistently show a better blister emptying when the filled blisters are sonicated, when the filling vacuum is lower, and when plug shape is elongated.
- Figure 11 is a graph showing the results of the sonicating trial discussed above.
- Blister Details Cold formed blister base sealed to lid using Belco Blister Sealer.
- Blister base material Aluminium-PVC Laminate foil COS_VEC_017 (Alcan)
- Blister lid material Aluminium-PVC Laminate foil COS_VEC_004 (Alcan)
- Example 6 The data in Table 6.1 demonstrate the effect of sonication on Formulation 2 as demonstrated by shot weight as a percentage of fill weight.
- Blister sonication parameters varied. Pulse duration varied from 0.1 to 1 second, pressure 0 4 to 1 bar and amplitude varied from 50 to 100% in each of these.
- the formulation was: Apomorphine HCl 30% Respitose70% and the blisters were Table Top Filled using a 16.695 mm 3 drum.
- the break-up of powder compacts formed upon filling receptacles may be further assisted by modifications made to the dry powder formulation itself.
- this sieving is coupled with agitation of the powder in a blister or capsule to break up the compacted powder, as outlined above.
- Sieving may be carried out by passing the powder through a sieve, preferably one with a size range of 50 to 1,000 ⁇ m.
- the powder may be passed through a CoMiIl (available from Quadro).
- the break up of compacted powder is assisted by the inclusion of a pelletisation step to form small metastable pellets prior to filling.
- the pellet stability or strength is an issue, as it must survive the filling process. However, it is also important that the individual pellets resist forming strong bonds with adjacent pellets, to reduce the likelihood of the formation of stable compacts.
- Various methods may be used to form the metastable pellets, including granulation, co- milling, extrusion, tumbling. The processes may be carried out in the presence of a volatile additive, to aid the process, or it may be a dry process.
- the formation of compacted powder may be reduced by including an additive material in the dry powder formulation which reduces the cohesion and/or adhesion of adjacent particles.
- the coating of powder particles with such an additive material which may also be referred to as a force control agent or FCA, does not necessarily prevent the formation of agglomerates of powder particles or compacted powder. However, it does reduce the cohesive forces between particles, thereby reducing the stability of the agglomerates and compacts so that they are more easily disrupted, for example by the agitation steps mentioned above.
- Suitable additive materials are discussed at length in International Patent Publication No. WO 02/43701 and these include anti- adherent or anti-friction agents including amino acids such as leucine, phospholipids such as lecithin and metal stearates such as magnesium stearate.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Basic Packing Technique (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07733567A EP1996264A1 (en) | 2006-03-22 | 2007-03-22 | Improvements in treatment of dry powder formulations |
CA002646420A CA2646420A1 (en) | 2006-03-22 | 2007-03-22 | Improvements in treatment of dry powder formulations |
JP2009500938A JP2009530007A (en) | 2006-03-22 | 2007-03-22 | Improved processing of dry powder formulations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0605676.6 | 2006-03-22 | ||
GBGB0605676.6A GB0605676D0 (en) | 2006-03-22 | 2006-03-22 | Improvements in extraction of powder formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007107796A1 true WO2007107796A1 (en) | 2007-09-27 |
Family
ID=36383903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/050142 WO2007107796A1 (en) | 2006-03-22 | 2007-03-22 | Improvements in treatment of dry powder formulations |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1996264A1 (en) |
JP (1) | JP2009530007A (en) |
CN (1) | CN101454039A (en) |
CA (1) | CA2646420A1 (en) |
GB (1) | GB0605676D0 (en) |
WO (1) | WO2007107796A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009055030A2 (en) * | 2007-10-25 | 2009-04-30 | Nektar Therapeutics | Powder conditioning of unit dose drug packages |
AU2012258357B2 (en) * | 2007-10-25 | 2014-02-27 | Novartis Ag | Powder conditioning of unit dose drug packages |
EP2830751A1 (en) * | 2012-03-30 | 2015-02-04 | Vectura Limited | Method and apparatus |
US9179691B2 (en) | 2007-12-14 | 2015-11-10 | Aerodesigns, Inc. | Delivering aerosolizable food products |
US10744278B2 (en) | 2014-07-07 | 2020-08-18 | Microdose Therapeutx, Inc. | Inhalation device |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111361805A (en) * | 2020-03-30 | 2020-07-03 | 海宁市万路针织有限公司 | Binding apparatus for socks |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041031A1 (en) * | 1996-04-26 | 1997-11-06 | Inhale Therapeutic Systems | Powder filling systems, apparatus and methods |
WO2001043802A1 (en) * | 1999-12-17 | 2001-06-21 | Inhale Therapeutic Systems, Inc. | Systems and methods for treating packaged powders |
WO2002087737A1 (en) * | 2001-05-01 | 2002-11-07 | Glaxo Group Limited | Deagglomerator apparatus and method |
WO2003095010A2 (en) * | 2002-05-10 | 2003-11-20 | Oriel Therapeutics, Inc. | Dry powder inhalers for use with piezoelectric polymer-driven delivery means, and associated blister package comprising a piezoelectric polymer material |
-
2006
- 2006-03-22 GB GBGB0605676.6A patent/GB0605676D0/en not_active Ceased
-
2007
- 2007-03-22 WO PCT/GB2007/050142 patent/WO2007107796A1/en active Application Filing
- 2007-03-22 CN CNA200780019049XA patent/CN101454039A/en active Pending
- 2007-03-22 JP JP2009500938A patent/JP2009530007A/en active Pending
- 2007-03-22 CA CA002646420A patent/CA2646420A1/en not_active Abandoned
- 2007-03-22 EP EP07733567A patent/EP1996264A1/en not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041031A1 (en) * | 1996-04-26 | 1997-11-06 | Inhale Therapeutic Systems | Powder filling systems, apparatus and methods |
WO2001043802A1 (en) * | 1999-12-17 | 2001-06-21 | Inhale Therapeutic Systems, Inc. | Systems and methods for treating packaged powders |
WO2002087737A1 (en) * | 2001-05-01 | 2002-11-07 | Glaxo Group Limited | Deagglomerator apparatus and method |
WO2003095010A2 (en) * | 2002-05-10 | 2003-11-20 | Oriel Therapeutics, Inc. | Dry powder inhalers for use with piezoelectric polymer-driven delivery means, and associated blister package comprising a piezoelectric polymer material |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009055030A2 (en) * | 2007-10-25 | 2009-04-30 | Nektar Therapeutics | Powder conditioning of unit dose drug packages |
WO2009055030A3 (en) * | 2007-10-25 | 2009-06-18 | Nektar Therapeutics | Powder conditioning of unit dose drug packages |
JP2011500268A (en) * | 2007-10-25 | 2011-01-06 | ノバルティス アーゲー | Powder preparation of unit dose drug package |
AU2012258357B2 (en) * | 2007-10-25 | 2014-02-27 | Novartis Ag | Powder conditioning of unit dose drug packages |
US9179691B2 (en) | 2007-12-14 | 2015-11-10 | Aerodesigns, Inc. | Delivering aerosolizable food products |
EP2830751A1 (en) * | 2012-03-30 | 2015-02-04 | Vectura Limited | Method and apparatus |
US10744278B2 (en) | 2014-07-07 | 2020-08-18 | Microdose Therapeutx, Inc. | Inhalation device |
Also Published As
Publication number | Publication date |
---|---|
CA2646420A1 (en) | 2007-09-27 |
GB0605676D0 (en) | 2006-05-03 |
JP2009530007A (en) | 2009-08-27 |
EP1996264A1 (en) | 2008-12-03 |
CN101454039A (en) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1996264A1 (en) | Improvements in treatment of dry powder formulations | |
RU2517140C2 (en) | Method of processing package with single medication dose | |
US7334577B2 (en) | Synthetic jet based medicament delivery method and apparatus | |
JP4976514B2 (en) | Powder flow rate control device and control method | |
JP4917229B2 (en) | System and method for processing packaged powder | |
JP2016165510A (en) | Inhalation device and method | |
JP2001519296A (en) | Apparatus and method for powder filling | |
FI111331B (en) | Method and apparatus for manufacturing a drug concentrate | |
EP2249970B1 (en) | Method and apparatus for driving a transducer of an inhalation device | |
EP3171920B1 (en) | Dry powder nebulizer | |
WO2016014153A1 (en) | Dry powder nebulizer | |
KR102235192B1 (en) | Inhalation device | |
JP2004533917A (en) | Deagglomeration apparatus and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780019049.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07733567 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2646420 Country of ref document: CA Ref document number: 2009500938 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007733567 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5698/CHENP/2008 Country of ref document: IN |